Literature DB >> 18756349

Lipid peroxidation and antioxidant status in patients with breast cancer.

C P Rajneesh1, A Manimaran, K R Sasikala, P Adaikappan.   

Abstract

INTRODUCTION: The present study was undertaken to evaluate the status of lipid peroxidation and antioxidants as biomarkers in human plasma.
METHODS: The extent of lipid peroxidation as evidenced by the formation of thiobarbituric acid reactive substances (TBARS) and conjugated dienes (CD) as well as the status of the antioxidants superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH), glutathione peroxidase (GPx) and glutathione S-transferase (GST) in serum samples of 40 breast cancer patients in and around Coimbatore, India, were studied. Controls consisted of members of the public with no previous history of breast cancer or other cancer-related diseases.
RESULTS: The plasma samples of the breast cancer patients showed enhanced level of lipid peroxidation when compared to the corresponding controls. This was accompanied by a significant elevation in both enzymic and non-enzymic antioxidants.
CONCLUSION: These findings indicate the significant increase in lipid peroxidation as evidenced by the level of TBARS and antioxidant status such as elevated SOD, CAT, GPx, GSH and GST in samples from breast cancer patients compared to controls.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18756349

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  28 in total

1.  Effects of physical activity on systemic oxidative/DNA status in breast cancer survivors.

Authors:  Barbara Tomasello; Giuseppe Antonio Malfa; Angela Strazzanti; Santi Gangi; Claudia Di Giacomo; Francesco Basile; Marcella Renis
Journal:  Oncol Lett       Date:  2016-11-30       Impact factor: 2.967

2.  Apoptosis, angiogenesis, inflammation, and oxidative stress: basic interactions in patients with early and metastatic breast cancer.

Authors:  Enas A Hamed; Madeha M Zakhary; Doaa W Maximous
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-24       Impact factor: 4.553

3.  Changes in oxidative stress and insulin resistance in morbidly obese patients after bariatric surgery.

Authors:  Mora Murri; Eduardo García-Fuentes; José Manuel García-Almeida; Lourdes Garrido-Sánchez; María Dolores Mayas; Rosa Bernal; Francisco J Tinahones
Journal:  Obes Surg       Date:  2010-03       Impact factor: 4.129

4.  Serum total oxidant/antioxidant status and trace element levels in breast cancer patients.

Authors:  Jia-Fu Feng; Ling Lu; Ping Zeng; Yun-Hong Yang; Jun Luo; Yu-Wei Yang; Dong Wang
Journal:  Int J Clin Oncol       Date:  2011-10-05       Impact factor: 3.402

5.  Breast fine-needle aspiration malondialdehyde deoxyguanosine adduct in breast cancer.

Authors:  Marco Peluso; Armelle Munnia; Gabriella G Risso; Sandra Catarzi; Sara Piro; Marcello Ceppi; Roger W Giese; Beniamino Brancato
Journal:  Free Radic Res       Date:  2011-01-21

6.  Therapeutic Effects of Newly Synthesized Boron Compounds (BGM and BGD) on Hepatocellular Carcinoma.

Authors:  Meliha Koldemir Gündüz; Melda Bolat; Güllü Kaymak; Derya Berikten; Dursun Ali Köse
Journal:  Biol Trace Elem Res       Date:  2021-02-26       Impact factor: 3.738

Review 7.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

8.  Correlation of α-Lipoic Acid and S. Glutathione Level with Free Radical Excess in Tobacco Consumers.

Authors:  Suman Sharma; Manjinder Kaur; M L Suhalka; Chanchal Shrivastav
Journal:  J Clin Diagn Res       Date:  2016-04-01

9.  Oxidative Stress and Anti-oxidants in Pre and Post-operative Cases of Breast Carcinoma.

Authors:  Sohail Hussain; Mohammad Ashafaq
Journal:  Turk J Pharm Sci       Date:  2018-11-20

10.  Protein modifications as potential biomarkers in breast cancer.

Authors:  Hongjun Jin; Richard C Zangar
Journal:  Biomark Insights       Date:  2009-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.